Analyses of the prognostic impact of IDH mutations in AMLs emerged as a matter of great controversy, with contrasting evidence either supporting a positive, a negative, or a neutral impact on AML prognosis [121]. This evidence concerns the gene IDH1 and acute myeloid leukemia.